Abstract
Gestational trophoblastic disease comprises a group of rare, and potentially malignant, conditions that arise from abnormal trophoblastic proliferation. When there is invasion and evidence of metastatic disease, gestational trophoblastic neoplasia is used. While chemotherapy is the mainstay of treatment for gestational trophoblastic neoplasia, the role of surgery has come full circle in recent years. Before the introduction of highly effective systemic treatment options, surgery was the default treatment. Surgery for gestational trophoblastic neoplasia often yielded unsatisfactory results and mortality remained high. In recent years, the role of adjuvant surgery in the management of gestational trophoblastic neoplasia has been examined with great interest. We aim to provide an overview of the various surgical approaches employed in managing gestational trophoblastic neoplasia, including their indications, techniques, and outcomes. Additionally, we discuss whether there is a role to do less in surgery for gestational trophoblastic neoplasia and describe our experience with a modified surgical technique for its treatment. By summarizing the current evidence, this article highlights the significant contributions of surgery to the holistic management of patients with gestational trophoblastic neoplasia and provides a framework on which to base management and treatment programs.
Reference41 articles.
1. Choriocarcinoma incidence in the United States;Brinton;Am J Epidemiol,1986
2. Changing trends in gestational trophoblastic disease;Smith;J Reprod Med,2006
3. p53, p21, Rb and mdm2 oncoproteins. expression in normal placenta, partial and complete mole, and choriocarcinoma;Fulop;J Reprod Med,1998
4. Choriocarcinoma in women: analysis of a case series with genotyping;Savage;Am J Surg Pathol,2017
5. Effect of Methotrexate Therapy upon Choriocarcinoma and Chorioadenoma